Doblinger J
ORCID: 0000-0003-3534-4244
· 1 paper in corpus
ObjectiveTo summarize efficacy and safety data on a new progesterone compound which is available for subcutaneous administration as compared to vaginally administered progesterone for luteal phase support in patients undergoing IVF treatmen…